Pemetrexed
- Product NDC
- 50742-341
- 11-digit product format
- 507420341
- Labeler code
- 50742
- Product ID
- 50742-341_12d4ace5-4ce2-469a-9a42-380a68328670
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pemetrexed disodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- ANDA204890
- Marketing category
- ANDA
- Marketing start
- 2022-05-24
- Marketing end
- 0000-00-00
- Substance
- PEMETREXED DISODIUM HEMIPENTAHYDRATE
- Active strength
- 500 mg/20mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50742-341 | PEMETREXED (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [INGENUS PHARMACEUTICALS, LLC] | 3 | Legacy NDC | 20231229_0346155f-a455-4044-8d5f-eacb97a8c8f0.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50742-341-01 | 50742034101 | 1 VIAL in 1 CARTON (50742-341-01) > 20 mL in 1 VIAL | 1 vial | 2022-05-24 | 0000-00-00 | No | No | Current |